In vitro anti-acetyl cholinesterase and antioxidant activity of selected Malaysian plants

The aim of this study is to discover and identify the potential plant extracts that could be vital against Alzheimer’s disease (AD). It is a neurodegenerative disease affecting the brain. The most promising target for the symptomatic treatment and slowing of AD progression is cholinesterase inhibito...

Penerangan Penuh

Disimpan dalam:
Butiran Bibliografi
Pengarang-pengarang Utama: Nour, Azhari H., Khan, Muhammad, Sulaiman, Ahmad Ziad, Batool, Tahira, Nour, Abdulrahman H., Khan, Muhammad Mumtaz, Kormin, Faridah
Format: Artikel
Diterbitkan: Inovare Academic Science 2014
Subjek-subjek:
Capaian Atas Talian:https://innovareacademics.in/journals/index.php/ajpcr/article/view/1169
https://innovareacademics.in/journals/index.php/ajpcr/article/view/1169
Penanda-penanda: Tambah Penanda
Tiada Penanda, Jadilah orang pertama menanda rekod ini!
Penerangan
Ringkasan:The aim of this study is to discover and identify the potential plant extracts that could be vital against Alzheimer’s disease (AD). It is a neurodegenerative disease affecting the brain. The most promising target for the symptomatic treatment and slowing of AD progression is cholinesterase inhibitors from plants. To evaluate the antioxidant and anti-acetylcholinesterase (AChEI) activities of leaves and roots macerated and refluxed with ethanol extracts, from four medicinal plants, namely; C.asiatica, M.pudica, C.pumila,and L.camara. DPPH and β-carotene assays were used to determine antioxidant activity; whereas Ellman’s colorimetric method was adopted to quantify AChEI activity. Among all tested samples, the refluxed ethanol extract ofM.pudicaleaves exhibited the highest AChEI activity (IC50 = 0.0114 mg/ml) whereas, M. pudica roots showed high antioxidant activity (DPPH; IC50 = 0.0102 mg/ml). Results reveal that all plant extracts studied possess anti-oxidant properties. Most potent extracts could be a lead to novel antioxidants and acetyl cholinesterase inhibitors, for the treatment of AD.